>>CyberKnife Center of Chicago will open on Aug 10, 2009
http://www.emhc.org/about/emhcnews/pressreleases/individual.cfm?pid=C7D4671F-F39B-8CE2-E4974A9E225D4656
CyberKnife Center of Chicago offers cancer patients new hope
For immediate release, July 29, 2009
Contact
Kyle Bauer, Public Relations Coordinator, 630-993-5702
ELMHURST — As part of a $6 million project, a new cancer treatment facility, CyberKnife Center of Chicago, will open on Aug. 10 on the campus of Elmhurst Memorial Hospital. The center will house the first new generation CyberKnife system in the Greater Chicago area, providing approximately 9.5 million residents access to the most advanced form of cancer treatment with the world's first and only robotic radiosurgery system.
Using image guidance technology and computer-controlled robotics, the CyberKnfie system tracks and destroys tumors in the body while accounting for changes in location due to breathing and normal internal movements. An alternative to, or complement for, traditional radiation therapy, the machine has the ability to deliver precise beams of high-dose radiation to a wide range of locations, including those in the brain, spine, lung, liver, pancrease and prostate. The CyberKnfie is entirely non-invasive, painless, requires no anesthesia or recovery time and allows patients to return immediately to normal activities. Additionally, its sub-millimeter accuracy eliminates damage to healthy tissue surrounding a tumor site.
CyberKnife 8.5, the new generation machine at CyberKnife Center of Chicago, features a higher energy source than previous machines, which allows for enhanced calculations of radiation doses and planning, as well as a device that controls the size of the radiation beam, providing reduced treatment time and greater protection of normal tissue. Treatments with CyberKnife are typically completed in one to five visits depending on the number and size of tumors.
CyberKnife Center of Chicago was made possible through a partnership between Nuclear Oncology Medical Care, Elmhurst Memorial Hospital and US Radiosurgery. The center is located in the Radiation Oncology Department at Elmhurst Memorial Hospital.
Founded in 1926 as the first hospital in DuPage County, Elmhurst Memorial Hospital, now Elmhurst Memorial Healthcare, has expanded its services to include several Care Centers conveniently located to better serve surrounding communities. The organization includes a hospital with 427 licensed inpatient beds and a staff of more than 3,000 employees and 600 physicians.
Nuclear Oncology Medical Care is a group practice of 10 radiation oncologists that has served the Chicago area since 1972. Nuclear Oncology Medical Care's involvement in the CyberKnife Center of Chicago is in keeping with its long-standing mission to bring leading edge radiation oncology technologies to the area. Its physicians were the first to provide intensity modulated radiation therapy in a private practice setting and pioneered the use of neutron therapy.
US Radiosurgery establishes partnerships with physicians and hospitals to develop and manage stereotactic radiosurgery services (SRS) in communities across the country. US Radiosurgery's founders have more than 75 years of combined experience in partnering with physicians and hospitals. The company's headquarters are in Nashville, Tenn.
For more information about CyberKnife Center of Chicago, visit www.ChicagoCK.com
CyberKnife Center of Chicago offers cancer patients new hope
For immediate release, July 29, 2009
Contact
Kyle Bauer, Public Relations Coordinator, 630-993-5702
ELMHURST — As part of a $6 million project, a new cancer treatment facility, CyberKnife Center of Chicago, will open on Aug. 10 on the campus of Elmhurst Memorial Hospital. The center will house the first new generation CyberKnife system in the Greater Chicago area, providing approximately 9.5 million residents access to the most advanced form of cancer treatment with the world's first and only robotic radiosurgery system.
Using image guidance technology and computer-controlled robotics, the CyberKnfie system tracks and destroys tumors in the body while accounting for changes in location due to breathing and normal internal movements. An alternative to, or complement for, traditional radiation therapy, the machine has the ability to deliver precise beams of high-dose radiation to a wide range of locations, including those in the brain, spine, lung, liver, pancrease and prostate. The CyberKnfie is entirely non-invasive, painless, requires no anesthesia or recovery time and allows patients to return immediately to normal activities. Additionally, its sub-millimeter accuracy eliminates damage to healthy tissue surrounding a tumor site.
CyberKnife 8.5, the new generation machine at CyberKnife Center of Chicago, features a higher energy source than previous machines, which allows for enhanced calculations of radiation doses and planning, as well as a device that controls the size of the radiation beam, providing reduced treatment time and greater protection of normal tissue. Treatments with CyberKnife are typically completed in one to five visits depending on the number and size of tumors.
CyberKnife Center of Chicago was made possible through a partnership between Nuclear Oncology Medical Care, Elmhurst Memorial Hospital and US Radiosurgery. The center is located in the Radiation Oncology Department at Elmhurst Memorial Hospital.
Founded in 1926 as the first hospital in DuPage County, Elmhurst Memorial Hospital, now Elmhurst Memorial Healthcare, has expanded its services to include several Care Centers conveniently located to better serve surrounding communities. The organization includes a hospital with 427 licensed inpatient beds and a staff of more than 3,000 employees and 600 physicians.
Nuclear Oncology Medical Care is a group practice of 10 radiation oncologists that has served the Chicago area since 1972. Nuclear Oncology Medical Care's involvement in the CyberKnife Center of Chicago is in keeping with its long-standing mission to bring leading edge radiation oncology technologies to the area. Its physicians were the first to provide intensity modulated radiation therapy in a private practice setting and pioneered the use of neutron therapy.
US Radiosurgery establishes partnerships with physicians and hospitals to develop and manage stereotactic radiosurgery services (SRS) in communities across the country. US Radiosurgery's founders have more than 75 years of combined experience in partnering with physicians and hospitals. The company's headquarters are in Nashville, Tenn.
For more information about CyberKnife Center of Chicago, visit www.ChicagoCK.com
Posts
No comments:
Post a Comment